Doctor Joaquin Llacer adderesses the Vitamin De implication in reproductive medicine within the Campus Angelini webinar
Reproductive medicine development is achieved with a multidisciplinary perspective. Advances that arise by leaps and bounds and that allow us to offer better and more successful treatments. At Instituto Bernabeu, the care vocation is accompanied by an important research effort and, in turn, a work to disseminate current evidence that can improve treatments.
This Thursday, January 28, the Instituto Bernabeu medical co-director, Dr Joaquin Llacer, has participated in the Angelini Campus, an online meeting for specialists, in which the expert has addressed the involvement of Vitamin D in reproductive medicine.
Vitamin D is a global metabolic regulator, it allows the absorption of calcium, keeps blood pressure stable and helps the correct absorption of insulin from the cells. Its deficiency affects different physical processes and also fertility. Hence, before starting a treatment it is necessary to analyse its levels. During pregnancy, if these levels are very low it can generate hypertension and cause disorders that end in pre-eclampsia. Poor regulation of this vitamin can also trigger gestational diabetes. Pregnancy may end with a caesarean section and at the same time, the birth of a low-weight baby.
Dr Llacer emphasizes that regulated levels of Vitamin D favour pregnancy as the presence of receptors for Vitamin D in the endometrium plays an important role in embryo implantation. In addition, a proper balance also reduces miscarriage risk.
At Instituto Bernabeu, the study of Vitamin D and its implication in reproductive health has been present in the Endocrinology unit for more than a decade.